SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc., a privately held biotechnology company and developer of the PLAC® test, today announced the appointment of Charles (Chuck) Patrick to its Board of Directors. Patrick brings nearly 30 years of experience working with and managing high growth diagnostic companies with an emphasis in the areas of sales, marketing, and global distribution.
